Human trials projected to start in early 2010.

Primary Investigator

Randy Craven, MD will be the Primary Investigator for the Phase II study for the Oculieve drainage device. Dr. Craven is an Associate Clinical Professor of Ophthalmology at the University of Colorado School of Medicine and is a surgeon at Specialty Eye Care with offices in Parker and Denver, Colorado. (more info)